mAbDx has been awarded a highly competitive Small Business Innovative Research (SBIR) grant from the United States Department of Agriculture, National Institute of Food and Agriculture (USDA, NIFA). The project goal is to develop an inexpensive diagnostic "dipstick" test for Vibrio tubiashii (Vt), a bacterial shellfish pathogen that causes serious …
read moremAbDx research presented at EUROMIT 2014 - International Meeting on Mitochondrial Pathology
mAbDx CSO Michael Marusich presented current mAbDx research on mitochondrial DAMPs (Damage Associated Molecular Patterns) at the 9th EUROMIT – International Meeting on Mitochondrial Pathology, in Tampere, Finland, June 15-19, 2014. More than 750 leading mitochondrial researchers attended the conference which is one of the world’s leading scientific meetings on …
read moreOregon State University and mAbDx agree to develop diagnostic tools for managing vibriosis in marine shellfish hatcheries
mAbDx and Oregon State University have agreed to jointly develop rapid tests and reagents for diagnosis of vibriosis in marine shellfish hatcheries. Vibrio tubiashii (Vt) is a bacterial shellfish pathogen that causes serious disruptions in hatchery production and is currently difficult to detect and manage. The novel diagnostic test is …
read moremAbDx Chief Scientific Officer Michael Marusich, Ph.D., presents recent research to identify and characterize new mtDAMPs that drive the Systemic Inflammatory Response Syndrome (SIRS) after trauma
mAbDx Chief Scientific Officer Michael Marusich, Ph.D., presented a research report titled “Defining the contribution of mitochondrial peptides to SIRS after tissue injury” at the 2013 Mérieux Research Grants Meeting, held in Annecy, France, Sept 11-13. The work is a collaborative research project by Michael Marusich, Ph.D., mAbDx …
read moremAbDx moves into a new custom-built biotechnology laboratory in the recently completed Lewis Integrative Sciences Building on the University of Oregon campus
mAbDx has relocated into private laboratory and office space in the newly completed Lewis Integrative Sciences Building on the campus of the University of Oregon. The laboratory is designed for biotechnology research, in particular the development, characterization and validation of novel monoclonal antibodies and immunoassays.
read more